Stereotaxis, Medtech announce catheter approved by China’s NMPA

Stereotaxis (STXS) and Shanghai MicroPort EP Medtech announced that the Magbot Magnetic Navigation Ablation Catheter has received regulatory approval from China’s National Medical Products Administration, NMPA. The Magbot Catheter is a single-use magnetic saline-irrigated radiofrequency ablation catheter designed and developed by MicroPort EP in collaboration with Stereotaxis. The catheter works exclusively and in tight conjunction with Stereotaxis’ robotic systems, including the recently NMPA-approved Genesis RMN, and MicroPort EP’s Columbus 3D EP Mapping System.